I love Allan Harris' math! "The math is actually

I love Allan Harris' math!

"The math is actually quite simple. Kevetrin should equal at least $2.50 per share. Prurisol should be worth at least $1.00 per share. That's $3.50 per share as 2012 winds to a close. In the first half of 2013, Kevetrin could be worth $4.50 per share and Prurisol $2.00 per share, putting shares at $6.50. I think that I have explained why CTIX could be at $13 per share by the end of the year if data on Prurisol and Kevetrin continues to accumulate in the frantic and optimistic manner that it has to date."